PEPID Pulse
  • Blog
  • Alerts
  • Press
  • pepid.com
Select Page
New Indication for Zerbaxa (ceftolozan & tazobactam) Battles Antimicrobial-resistant Infections

New Indication for Zerbaxa (ceftolozan & tazobactam) Battles Antimicrobial-resistant Infections

by PEPID Newsroom | Jun 4, 2019 | Alerts

The U.S. FDA approved a new indication for Zerbaxa (Ceftolozane and tazobactam) for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABD/VABP) in patients 18 years and older. This approval addresses the threat of...

Recent Posts

  • Autism Acceptance Month: Autism in Clinical Practice—Communication Strategies and Considerations for Better Care
  • Sleep Awareness Week: Why Sleep Health Should Be Part of Every Wellness Visit
  • Heart Health Month in Practice: What Clinicians Should Watch for in February
  • National Blood Donor Month: How Clinicians Can Encourage Lifesaving Donations
  • Holiday Health Hazards: Common ER Visits and How to Prevent Them

Categories

  • Alerts
  • Emergency Medicine
  • Featured Posts
  • Nursing
  • Pharmacy
  • Press & Media
  • Primary Care
  • Uncategorized
PEPID, LLC. All rights reserved